Published in Int J Radiat Biol on June 01, 2001
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo. Blood (2011) 2.14
Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival. Radiat Res (2009) 1.31
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging (2010) 1.14
Dietary antioxidants protect hematopoietic cells and improve animal survival after total-body irradiation. Radiat Res (2008) 1.09
Radioprotective effects of oral 17-dimethylaminoethylamino-17-demethoxygeldanamycin in mice: bone marrow and small intestine. Cell Biosci (2013) 1.05
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. Br J Cancer (2011) 1.00
Radiobiology of the acute radiation syndrome. Rep Pract Oncol Radiother (2011) 0.94
The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse. Int J Exp Pathol (2005) 0.90
Proteomics in radiation research: present status and future perspectives. Radiat Environ Biophys (2013) 0.90
Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse. Int J Exp Pathol (2008) 0.87
Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques. AIDS Res Hum Retroviruses (2009) 0.87
Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation. PLoS One (2015) 0.86
Identification and quantitation of biomarkers for radiation-induced injury via mass spectrometry. Health Phys (2014) 0.86
Correlation of plasma FL expression with bone marrow irradiation dose. PLoS One (2013) 0.83
Intestinal microbiota-derived metabolomic blood plasma markers for prior radiation injury. Int J Radiat Oncol Biol Phys (2015) 0.79
The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice. Int J Clin Exp Pathol (2014) 0.75
The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. Int J Exp Pathol (2008) 0.75
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell (1999) 8.07
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth (1992) 3.50
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol (2000) 2.71
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods (1989) 2.56
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2007) 2.51
Numbers of Giardia in the feces of infected children. Am J Trop Med Hyg (1975) 2.38
The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene (1995) 2.19
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem (2001) 2.09
Studies of electroimmunodiffusion: immunochemical quantitation of proteins in dilute solutions. Immunochemistry (1969) 2.05
Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Aliment Pharmacol Ther (2012) 2.03
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation. Lancet (1992) 1.99
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med (1987) 1.98
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.91
Laparoscopic adjustable silicone gastric banding in the treatment of morbid obesity. A preliminary report. Surg Endosc (1994) 1.87
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A (1998) 1.87
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Electrocautery as a factor in seroma formation following mastectomy. Am J Surg (1998) 1.75
Physiological outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke (1995) 1.73
Thoracoscopic repair of H-type tracheoesophageal fistula in the newborn: a technical case report. J Pediatr Surg (2004) 1.72
Clinical phenotype associated with terminal 2q37 deletion. Clin Genet (1995) 1.63
Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1996) 1.62
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem (2001) 1.62
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol (1982) 1.51
Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol (2007) 1.50
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother (1991) 1.49
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol (2009) 1.46
Organ donors with primary central nervous system tumor. Transplantation (2000) 1.43
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. BJU Int (1999) 1.42
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol (1998) 1.42
Differences in serum potassium concentrations in normal men in different geographic locations. Clin Chem (1993) 1.40
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol (1989) 1.40
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med (2007) 1.39
Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia. Int J Radiat Biol (1995) 1.38
The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD. Proc Natl Acad Sci U S A (2000) 1.38
Assessment of cerebral oxygenation in neurocritical care patients: comparison of a new four wavelengths forehead regional saturation in oxygen sensor (EQUANOX®) with brain tissue oxygenation. A prospective observational study. Minerva Anestesiol (2014) 1.37
Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia (2003) 1.29
Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int Arch Allergy Appl Immunol (1974) 1.29
Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ (2009) 1.26
Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur J Immunol (1986) 1.25
Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that interacts with afadin. Gene (2000) 1.24
Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol (2006) 1.21
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. J Virol (2001) 1.15
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease. Inflamm Bowel Dis (2009) 1.13
Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia (2007) 1.13
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer (1986) 1.12
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
Children of chernobyl cleanup workers do not show elevated rates of mutations in minisatellite alleles. Radiat Res (2001) 1.11
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1997) 1.10
[A comparative study of the feasibility and limits of ambulatory surgery in infants under and over one year of age]. Ann Chir (2004) 1.08
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol (2009) 1.08
Wolff-Parkinson-White syndrome. Problems in evaluation of multiple accessory pathways and surgical therapy. Circulation (1972) 1.08
Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions. J Immunol (1969) 1.07
Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy (1994) 1.06
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06
Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun (1993) 1.06
Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol (1996) 1.06
Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem (1999) 1.06
Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase. Blood (1978) 1.06
Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem (1996) 1.06
Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat (1987) 1.05
Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life. Cell Immunol (1997) 1.04
Utility of the wavelet transform to analyze the stationarity of single ionic channel recordings. J Neurosci Methods (2000) 1.04
Disturbances of cardiac rhythm during anesthesia and surgery. JAMA (1971) 1.04
Measurement of IgG antibody and airborne antigen to control an industrial outbreak of hypersensitivity pneumonitis. J Occup Med (1983) 1.03
Electrophysiological and sleep alterations in experimental mouse rabies. Brain Res (1986) 1.03
Comparison of murine and human nectin1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin1 to gD and a gD-dependent pathway of entry. Virology (2001) 1.03
Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant (1999) 1.02
Relation between variation in copy number of ribosomal RNA encoding genes and size of harbouring chromosomes in Leishmania of subgenus Viannia. Mol Biochem Parasitol (1998) 1.02
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.02
A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol (2001) 1.02
Evaluation of the deswelling period in dextran-containing medium after corneal organ culture. Cornea (1997) 1.02
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg (1995) 1.01
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol (1988) 1.01
Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas (1997) 1.00
Agglutination kinetics. A method for quantitative red cell antigen assays. Vox Sang (1975) 1.00